Paroxysmal cough is an increasingly common condition that has been gaining more attention in the medical community. It is characterized by sudden, repeated episodes of coughing that can last for minutes or even hours. The condition can be debilitating and significantly reduce quality of life. Despite its prevalence, the cause of paroxysmal cough is still largely unknown. This article explores the current understanding of the condition, its diagnosis, and potential treatments.
Paroxysmal cough is a condition characterized by sudden, repeated episodes of coughing. The coughing fits can last for minutes or even hours and can be very severe. During these episodes, the person may experience shortness of breath, chest pain, or even vomiting. The coughing fits can occur at any time, day or night, and can be triggered by a variety of factors such as exercise, cold air, or even talking.
Due to the sudden onset of the coughing fits, diagnosis of paroxysmal cough can be difficult. Doctors typically start by ruling out other conditions that may be causing the coughing, such as asthma, allergies, or GERD. If these conditions are ruled out, then a diagnosis of paroxysmal cough is made. In order to confirm the diagnosis, doctors may use a variety of tests, such as chest X-rays, pulmonary function tests, or even a bronchoscopy. These tests are used to rule out other conditions and to look for any underlying causes of the coughing.
Unfortunately, there is no cure for paroxysmal cough. Treatment typically focuses on managing the symptoms and reducing the frequency and severity of the coughing fits. This can include avoiding triggers, such as cold air or exercise, and taking medications to reduce the inflammation in the airways. In some cases, doctors may recommend more aggressive treatments, such as steroids or immunotherapy. These treatments are typically used in cases where the coughing is severe and other treatments have not been successful.
Paroxysmal cough is an increasingly common condition that can be debilitating and significantly reduce quality of life. Despite its prevalence, the cause of paroxysmal cough is still largely unknown. Doctors typically diagnose the condition by ruling out other conditions and using tests to look for underlying causes. Treatment typically focuses on managing the symptoms and reducing the frequency and severity of the coughing fits. In some cases, more aggressive treatments, such as steroids or immunotherapy, may be necessary. With greater understanding of the condition, doctors will be better equipped to diagnose and treat paroxysmal cough, leading to improved respiratory health for those affected.
1.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
2.
New drug combination shows good results in patients with HPV-negative head and neck cancer
3.
high response rate when using a bispecific antibody to treat R/R multiple myeloma.
4.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
5.
Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant
1.
Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches
2.
A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies
3.
Progressive Insights in Hematology in the Digital Era
4.
Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations
5.
The importance of understanding normal serum osmolality
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation